Genistein, an epigenome modifier during cancer prevention

Epigenetics

Volumn 6, Issue 7, 2011, Pages 888-891

  Zhang, Yukun ^a   Chen, Hong ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cancer epigenetics; DNA methylation; Early life exposure; Histone code; Maternal genistein; Soy isoflavone

Indexed keywords

AGOUTI PROTEIN; DNA METHYLTRANSFERASE; GENISTEIN; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR FKHRL1; WNT PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER PREVENTION; CANCER SURVIVAL; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN STRUCTURE; COLON CANCER; COLON CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE ACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; IN VITRO STUDY; IN VIVO STUDY; NEOPLASM; NONHUMAN; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RETROPOSON; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 79960128700     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16315     Document Type: Article

References (56)

1. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KA, Watanabe S, Hamalainen EK, et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995; 125:757-770.
2. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129:758-767.
3. Badger TM, Ronis MJ, Simmen RC, Simmen FA. Soy protein isolate and protection against cancer. J Am Coll Nutr 2005; 24:146-149.
4. Martinez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res 2005; 166:177-211.
5. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991; 83:541-546.
6. Messina M, Messina V. Increasing use of soyfoods and their potential role in cancer prevention. J Am Diet Assoc 1991; 91:836-840.
7. IARC. Cancer incidence in five continents. Volume IX. IARC Sci Publ 2008; 1-837.
8. Perabo FG, Von Low EC, Ellinger J, von RA, Muller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008; 11:6-12.
9. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 2007; 16:538-545.
10. Banerjee S, Li Y, Wang Z, Sarkar F. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269:226-242.
11. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125:777-783.
12. Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest 2003; 21:744-757.
13. Peng JH, Zhu JD, Mi MT, Li FJ, Cai L, Dong JZ, et al. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur J Cancer Prev 2010; 19:110-119.
14. Wang J, Eltoum IE, Lamartiniere CA. Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett 2002; 186:11-18.
15. Hakkak R, Korourian S, Ronis MJ, Johnston JM, Badger TM. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett 2001; 166:27-32.
16. Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, et al. Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. J Nutr 2009; 139:474-481.
17. Luo H, Jiang BH, King SM, Chen YC. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer 2008; 60:800-809.
18. Yu Z, Tang Y, Hu D, Li J. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-beta1/Smad pathway. Biochem Biophys Res Commun 2005; 333:827-832.
19. Zhang Y, Chen H. Genistein attenuates WNT signaling by upregulating sFRP2 in a human colon cancer cell line. Exp Biol Med 2011; 236:714-722.
20. Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, et al. Downregulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem 2011; 112:78-88.
21. Ullah MF, Ahmad A, Zubair H, Khan HY, Wang Z, Sarkar FH, et al. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol Nutr Food Res 2010.
22. Bielecki A, Roberts J, Mehta R, Raju J. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 2011; 63:139-150.
23. Han H, Zhong C, Zhang X, Liu R, Pan M, Tan L, et al. Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells. Nutr Cancer 2010; 62:641-647.
24. Rahal OM, Simmen RC. PTEN and p53 crossregulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 2010; 31:1491-1500.
25. Ross SA. Evidence for the relationship between diet and cancer. Exp Oncol 2010; 32:137-142.
26. Nystrom M, Mutanen M. Diet and epigenetics in colon cancer. World J Gastroenterol 2009; 15:257-263.
27. Bernal AJ, Jirtle RL. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 2010; 88:938-944.
28. Doerge DR, Twaddle NC, Churchwell MI, Newbold RR, Delclos KB. Lactational transfer of the soy isoflavone, genistein, in Sprague-Dawley rats consuming dietary genistein. Reprod Toxicol 2006; 21:307-312.
29. Doerge DR, Churchwell MI, Chang HC, Newbold RR, Delclos KB. Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reprod Toxicol 2001; 15:105-110.
30. Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 2010; 1:101-116.
31. Molinie B, Georgel P. Genetic and epigenetic regulations of prostate cancer by genistein. Drug News Perspect 2009; 22:247-254.
32. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80.
33. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2007; 96:26-30.
34. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, et al. Genistein induces the p21WAF1/ CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 2008; 68:2736-2744.
35. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008; 123:552-560.
36. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.
37. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 2010; 116:66-76.
38. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002; 21:5427-5440.
39. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Methods Mol Biol 2009; 507:3-20.
40. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2007; 1775:138-162.
41. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J Nutr 2007; 137:223-228.
42. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005; 11:7033-7041.
43. Fang MZ, Jin Z, Wang Y, Liao J, Yang GY, Wang LD, et al. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 2005; 26:615-622.
44. Wang Z, Chen H. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116. Anticancer Res 2010; 30:4537-4545.
45. de LW, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci 2007; 12:471-491.
46. Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T. Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle 2005; 4:1522-1539.
47. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005; 19:877-890.
48. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17:9-26.
49. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzledrelated protein genes in colorectal tumor. World J Gastroenterol 2006; 12:7113-7117.
50. Aguilera O, Munoz A, Esteller M, Fraga MF. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease. Endocr Metab Immune Disord Drug Targets 2007; 7:13-21.
51. Day JK, Bauer AM, DesBordes C, Zhuang Y, Kim BE, Newton LG, et al. Genistein alters methylation patterns in mice. J Nutr 2002; 132:2419-24123.
52. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006; 114:567-572.
53. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295-304.
54. Okitsu CY, Hsieh CL. DNA methylation dictates histone H3K4 methylation. Mol Cell Biol 2007; 27:2746-2757.
55. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-428.
56. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009; 30:662-670.